A Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation

Description

This is a research study to compare the well-being (caregiver strain index) of caregivers of patients receiving home vs standard care after autologous hematopoietic stem cell transplant.

Conditions

Well-being of Caregivers (Caregiver Strain Index)

Study Overview

Study Details

Study overview

This is a research study to compare the well-being (caregiver strain index) of caregivers of patients receiving home vs standard care after autologous hematopoietic stem cell transplant.

A Randomized Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation

A Phase 2 Study of Home Care Following Autologous Hematopoietic Stem Cell Transplantation

Condition
Well-being of Caregivers (Caregiver Strain Index)
Intervention / Treatment

-

Contacts and Locations

Durham

Duke University Medical Center, Durham, North Carolina, United States, 27705

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Scheduled to undergo an autologous hematopoietic stem cell transplant for any cancer or non-cancer illness
  • * Age 18-80 years
  • * Karnofsky Performance Scale KPS\> 80
  • * Able to read/write English
  • * A home that is deemed, upon inspection, in suitable condition to serve as a medical home, within a 90-minute driving distance of Duke
  • * Lack of a caregiver
  • * Pregnant women
  • * Patients with a documented active infection prior to starting their preparative regimen. This includes grade 3 or higher viral, bacterial, or fungal infection.
  • * Use of homeopathic medications, prebiotics, or probiotics that may impact gut microbiota

Ages Eligible for Study

18 Years to 80 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Duke University,

Anthony Sung, MD, PRINCIPAL_INVESTIGATOR, Duke Health

Nelson Chao, MD, PRINCIPAL_INVESTIGATOR, Duke Health

Study Record Dates

2027-01-30